Patents by Inventor Philip Just Larsen

Philip Just Larsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes
    Patent number: 11267924
    Abstract: Polydiallylamine copolymers are copolymers comprising monomers of polydiallylamine and either polyvinlyamine or polyallylamine. Polydiallylamine copolymers are often crosslinked. The polydiallyamine copolymers are useful as pharmaceutical compositions and may be used in the treatment of type 2 diabetes and for mitigating the complications of type 2 diabetes.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: March 8, 2022
    Assignee: GENZYME CORPORATION
    Inventors: Pradeep K. Dhal, Robert J. Miller, Steven C. Polomoscanik, Philip Just Larsen, Thomas Huebschle, Thorsten Schmidt, Ian Davison, Peter D. McDonnell, Chinyere Agbugba
  • CROSSLINKED POLYDIALLYMINE COPOLYMERS FOR THE TREATMENT OF TYPE 2 DIABETES
    Publication number: 20160177019
    Abstract: Polydiallylamine copolymers are copolymers comprising monomers of polydiallylamine and either polyvinlyamine or polyallylamine. Polydiallylamine copolymers are often crosslinked. The polydiallyamine copolymers are useful as pharmaceutical compositions and may be used in the treatment of type 2 diabetes and for mitigating the complications of type 2 diabetes.
    Type: Application
    Filed: December 16, 2015
    Publication date: June 23, 2016
    Inventors: Pradeep K. DHAL, Robert J. MILLER, Steven C. POLOMOSCANIK, Philip Just LARSEN, Thomas HUEBSCHLE, Thorsten SCHMIDT, Ian DAVISON, Peter D. McDONNELL, Chinyere AGBUGBA
  • Lowering Serum Lipids
    Publication number: 20080280815
    Abstract: The present invention relates to a method for lowering serum lipids, eg. triglycerides and/or cholesterol in a subject comprising administering a GLP-1 agonist to said subject.
    Type: Application
    Filed: August 22, 2007
    Publication date: November 13, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Johan Selmer, Jeppe Sturise, Philip Just Larsen
  • Method of treating hot flushes with hexapeptides
    Patent number: 6011006
    Abstract: The present invention relates to a method of treating migraine, non-insulin dependent diabetes mellitus (type II diabetes), sepsis, inflammation and/or vasomotor disturbances. This method utilizes a hexapeptide of formula (I)A.sup.1 -A.sup.2 -A.sup.3 -A.sup.4 -A.sup.5 -A.sup.6 -Y (I)wherein A.sup.1, A.sup.2, A.sup.3, A.sup.4, A.sup.5, A.sup.6 and Y are as defined in the specification.
    Type: Grant
    Filed: March 3, 1999
    Date of Patent: January 4, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Christian Thomsen, Joel Martin, Nils Langeland Johansen, Philip Just Larsen, Rolf Hohlweg